Eosinophilia associated with bupropion

Int J Clin Pharm. 2013 Aug;35(4):532-4. doi: 10.1007/s11096-013-9803-y. Epub 2013 Jun 12.

Abstract

Case (description): A 48-year-old woman started treatment with bupropion 150 mg once daily for depressive symptoms. After 19 days she presented to her family physician complaining of myalgia and non-productive cough. The physical examination was normal and laboratory investigations showed an eosinophil count of 4.7 × 10(9)/L (0-0.5). The results of a basal test before to bupropion intake were within normal range including eosinophils (0.2 × 10(9)/L). After ruling out other causes of eosinophilia, the physician decided to gradually discontinue bupropion, and a marked decrease in absolute eosinophil count was subsequently observed.

Conclusion: To the best of our knowledge, this is the third published case of bupropion-related eosinophilia. Although, in light of the case presented, the prevalence of this adverse effect seems to be low, an awareness that bupropion can be a potential cause of eosinophilia may lead to the avoidance of unnecessary diagnostic tests or referral to other specialists.

Publication types

  • Case Reports

MeSH terms

  • Antidepressive Agents, Second-Generation / adverse effects*
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Bupropion / adverse effects*
  • Bupropion / therapeutic use
  • Cough / etiology
  • Depressive Disorder / drug therapy
  • Eosinophilia / chemically induced*
  • Eosinophilia / diagnosis
  • Female
  • Humans
  • Middle Aged
  • Myalgia / etiology

Substances

  • Antidepressive Agents, Second-Generation
  • Bupropion